Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy

Background and Aim Anti‐tumor necrosis factor alpha (TNF‐α) therapy is an effective therapy for Crohn's disease (CD). We investigated FoxP3+ and CD127− regulatory T cells (Tregs) before and after administration of anti‐TNF‐α therapy in CD. Methods Eight patients with active CD who had received...

Full description

Bibliographic Details
Main Authors: Toshimi Chiba, Mikiya Endo, Shoko Miura, Yuko Hayashi, Yoshiko Asakura, Kotaro Oyama, Takayuki Matsumoto
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:JGH Open
Subjects:
Online Access:https://doi.org/10.1002/jgh3.12259